Newsroom | 73918 results

Sorted by: Latest

General Health
-

DermaSensor startet in Deutschland über die DERMALYTICA-Sparte von ContraCare und expandiert nach Erhalt der CE-Kennzeichnung der Klasse IIb und der Zusammenarbeit mit dem NHS in Europa

MIAMI & NÜRNBERG, Deutschland--(BUSINESS WIRE)--DermaSensor Inc., ein führender Anbieter von KI-gestützter Technologie zur Einschätzung des Hautkrebsrisikos, gab heute die Markteinführung von DermaSensor in Deutschland durch eine Vertriebsvereinbarung mit der ContraCare GmbH bekannt. Dies stellt einen bedeutenden Meilenstein in der internationalen Expansion von DermaSensor dar, nachdem das Unternehmen kürzlich die CE-Kennzeichnung der Klasse IIb gemäß der Medizinprodukteverordnung (MDR) der Eur...
-

Enhanced Group Announces Proposed 1-for-10 Reverse Stock Split

NEW YORK--(BUSINESS WIRE)--Enhanced Group Inc. (NYSE: ENHA) (“Enhanced” or the “Company”) today announced that its Board of Directors has approved a 1-for-10 reverse stock split of its Class A and Class B common stock (the “Reverse Stock Split”). The Board's action has been consented to by the holder of the majority of the Company's outstanding voting power, acting by written consent in lieu of a special meeting of shareholders. No further shareholder vote or action is required or being request...
-

AstraZeneca Makes $2 Billion Strategic Equity Investment in Summit Therapeutics

MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (Nasdaq: SMMT) today announced key developments important to the company’s progress towards achieving its goal of making a significant difference in the lives of patients with cancer. Specifically, Summit has established agreements with AstraZeneca (LSE/STO/NYSE: AZN) for a strategic equity investment in Summit and a clinical collaboration focused on ivonescimab and sonesitatug vedotin (sone-ve). Moreover, Summit and AstraZeneca intend to evaluat...
-

Aldeyra Therapeutics to Host Regulatory Update Webcast

CONCORD, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced that the company will host a regulatory update webcast on Tuesday, September 29, 2026, at 8:00 a.m. ET. The update will focus on reproxalap, an investigational drug for the treatment of dry eye disease. A live audio webcast and slide presentation will be accessible from...
-

Medcor to Join the APM Group, Expanding Occupational Health Services Across North America

MCHENRY, Ill.--(BUSINESS WIRE)--Medcor, a leading provider of onsite and mobile occupational health services across the United States and Canada, today announced it has entered into an agreement to join the APM Group, subject to Federal Trade Commission approval. Medcor and APM, an international health and human services organization operating in 11 countries, will work together to expand access for employers and their employees to high-quality, independent, advocacy-based occupational health ca...
-

Molina Healthcare of Michigan and The MolinaCares Accord Award $160,000 in Grants to Genesee County-Area Organizations Addressing Social Determinants of Health

FLINT, Mich.--(BUSINESS WIRE)--Molina Healthcare of Michigan & The MolinaCares Accord Award $160,000 in grants to Genesee County organizations Addressing SDOH....
-

Mirion Technologies ospiterà la prima conferenza Mirion Connect EMEA/APAC a Bruxelles

BRUXELLES--(BUSINESS WIRE)--Mirion Technologies, un fornitore leader di soluzioni avanzate per la sicurezza delle radiazioni, ha annunciato oggi le date di Mirion Connect 2026 EMEA/APAC, la prima edizione regionale dell'azienda della sua conferenza Mirion Connect per Europa, Medio Oriente, Africa e la regione Asia-Pacifico. L'evento si terrà dal 29 settembre al 1º ottobre 2026 a Bruxelles, in Belgio. Mirion Connect, un evento organizzato negli Stati Uniti per 40 anni, riunisce i professionisti...
-

Mirion Technologies organizó por primera vez en Bruselas la conferencia Mirion Connect para Europa, Oriente Medio, África y Asia-Pacífico

BRUSELAS--(BUSINESS WIRE)--Mirion Technologies, proveedor líder de soluciones avanzadas de seguridad radiológica, anunció hoy la celebración de Mirion Connect 2026 para Europa, Oriente Medio, África y Asia-Pacífico, la primera edición regional de su conferencia Mirion Connect dirigida a estas regiones. El evento se celebrará del 29 de septiembre al 1 de octubre de 2026 en Bruselas, Bélgica. Mirion Connect, que se celebra en Estados Unidos desde hace 40 años, reúne durante una semana a profesion...
-

Mirion Technologies s’apprête à accueillir la première édition de la conférence Mirion Connect EMEA/APAC à Bruxelles

BRUXELLES--(BUSINESS WIRE)--Mirion Technologies, l’un des principaux fournisseurs de solutions de pointe en matière de sécurité des rayonnements, a annoncé aujourd’hui le lancement de Mirion Connect 2026 EMEA/APAC, la première édition régionale de sa conférence Mirion Connect dédiée à l’Europe, au Moyen-Orient, à l’Afrique et à la région Asie-Pacifique. L’événement se tiendra du 29 septembre au 1er octobre 2026 à Bruxelles, en Belgique. Organisé aux États-Unis depuis 40 ans, l’événement Mirion...
-

Mirion Technologies organiseert de inaugurale Mirion Connect EMEA/APAC-conferentie in Brussel

BRUSSEL--(BUSINESS WIRE)--Mirion Technologies, een vooraanstande leverancier van geavanceerde oplossingen voor stralingsveiligheid, kondigde vandaag Mirion Connect 2026 EMEA/APAC aan, de eerste regionale editie van de Mirion Connect-conferentie van het bedrijf voor Europa, het Midden-Oosten, Afrika en de regio Azië-Stille Oceaan. Het evenement gaat door van 29 september tot 1 oktober 2026, in Brussel, België. Mirion Connect, een evenement dat al 40 jaar in de Verenigde Staten wordt georganiseer...